nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.467	1	CpDpCtD
Bupropion—CYP2A6—Pilocarpine—glaucoma	0.057	0.167	CbGbCtD
Bupropion—CYP2E1—Pilocarpine—glaucoma	0.0376	0.11	CbGbCtD
Bupropion—SLC6A2—Clonidine—glaucoma	0.0292	0.0854	CbGbCtD
Bupropion—CYP2E1—Methazolamide—glaucoma	0.0254	0.0743	CbGbCtD
Bupropion—CYP2D6—Carteolol—glaucoma	0.0237	0.0692	CbGbCtD
Bupropion—CYP1A2—Betaxolol—glaucoma	0.0194	0.0567	CbGbCtD
Bupropion—CYP2D6—Betaxolol—glaucoma	0.016	0.0467	CbGbCtD
Bupropion—CYP2C9—Diclofenamide—glaucoma	0.0154	0.045	CbGbCtD
Bupropion—CYP2C9—Dorzolamide—glaucoma	0.0149	0.0435	CbGbCtD
Bupropion—CYP2C9—Methazolamide—glaucoma	0.0132	0.0387	CbGbCtD
Bupropion—CYP2D6—Methazolamide—glaucoma	0.0121	0.0354	CbGbCtD
Bupropion—CYP3A4—Pilocarpine—glaucoma	0.0114	0.0333	CbGbCtD
Bupropion—CYP1A2—Clonidine—glaucoma	0.0106	0.0311	CbGbCtD
Bupropion—CYP2D6—Timolol—glaucoma	0.0103	0.0301	CbGbCtD
Bupropion—CYP3A4—Brinzolamide—glaucoma	0.00894	0.0262	CbGbCtD
Bupropion—CYP2D6—Clonidine—glaucoma	0.00875	0.0256	CbGbCtD
Bupropion—CYP3A4—Dorzolamide—glaucoma	0.00864	0.0253	CbGbCtD
Bupropion—CYP3A4—Methazolamide—glaucoma	0.0077	0.0225	CbGbCtD
Bupropion—CYP3A4—Acetazolamide—glaucoma	0.00616	0.018	CbGbCtD
Bupropion—CYP3A4—Clonidine—glaucoma	0.00557	0.0163	CbGbCtD
Bupropion—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	8.57e-05	0.00437	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	8.56e-05	0.00437	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	8.32e-05	0.00424	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	8.31e-05	0.00424	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	8.19e-05	0.00418	CbGpPWpGaD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.19e-05	0.00417	CbGpPWpGaD
Bupropion—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.15e-05	0.00415	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.04e-05	0.0041	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—TXN—glaucoma	8.02e-05	0.00409	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	7.98e-05	0.00407	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.98e-05	0.00407	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—TGFB2—glaucoma	7.88e-05	0.00402	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.87e-05	0.00402	CbGpPWpGaD
Bupropion—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	7.75e-05	0.00395	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.56e-05	0.00385	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	7.37e-05	0.00376	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	7.15e-05	0.00365	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—TGFB2—glaucoma	6.98e-05	0.00356	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—SLC6A13—glaucoma	6.97e-05	0.00355	CbGpPWpGaD
Bupropion—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	6.94e-05	0.00354	CbGpPWpGaD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.9e-05	0.00352	CbGpPWpGaD
Bupropion—SLC6A2—Monoamine Transport—TNF—glaucoma	6.86e-05	0.0035	CbGpPWpGaD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.81e-05	0.00347	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	6.66e-05	0.0034	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	6.66e-05	0.00339	CbGpPWpGaD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.6e-05	0.00337	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	6.49e-05	0.00331	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.47e-05	0.0033	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.34e-05	0.00323	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	6.09e-05	0.00311	CbGpPWpGaD
Bupropion—SLC6A3—Monoamine Transport—TNF—glaucoma	6.08e-05	0.0031	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	5.93e-05	0.00303	CbGpPWpGaD
Bupropion—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	5.93e-05	0.00303	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	5.93e-05	0.00303	CbGpPWpGaD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	5.83e-05	0.00297	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—TGFB2—glaucoma	5.83e-05	0.00297	CbGpPWpGaD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.66e-05	0.00289	CbGpPWpGaD
Bupropion—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	5.64e-05	0.00288	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.61e-05	0.00286	CbGpPWpGaD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.61e-05	0.00286	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.59e-05	0.00285	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.59e-05	0.00285	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	5.55e-05	0.00283	CbGpPWpGaD
Bupropion—Palpitations—Clonidine—glaucoma	5.54e-05	0.000323	CcSEcCtD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.54e-05	0.00283	CbGpPWpGaD
Bupropion—Gastrointestinal disorder—Pilocarpine—glaucoma	5.53e-05	0.000323	CcSEcCtD
Bupropion—Gastrointestinal pain—Travoprost—glaucoma	5.52e-05	0.000322	CcSEcCtD
Bupropion—Loss of consciousness—Clonidine—glaucoma	5.51e-05	0.000321	CcSEcCtD
Bupropion—Feeling abnormal—Brinzolamide—glaucoma	5.49e-05	0.00032	CcSEcCtD
Bupropion—Mental disorder—Betaxolol—glaucoma	5.49e-05	0.00032	CcSEcCtD
Bupropion—Pain—Pilocarpine—glaucoma	5.48e-05	0.000319	CcSEcCtD
Bupropion—Constipation—Pilocarpine—glaucoma	5.48e-05	0.000319	CcSEcCtD
Bupropion—Cough—Clonidine—glaucoma	5.47e-05	0.000319	CcSEcCtD
Bupropion—Sweating—Timolol—glaucoma	5.47e-05	0.000319	CcSEcCtD
Bupropion—Dizziness—Apraclonidine—glaucoma	5.47e-05	0.000319	CcSEcCtD
Bupropion—Malnutrition—Betaxolol—glaucoma	5.46e-05	0.000318	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—GSTT1—glaucoma	5.46e-05	0.00278	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	5.4e-05	0.00275	CbGpPWpGaD
Bupropion—Urticaria—Dorzolamide—glaucoma	5.39e-05	0.000314	CcSEcCtD
Bupropion—Epistaxis—Timolol—glaucoma	5.38e-05	0.000314	CcSEcCtD
Bupropion—Abdominal pain—Dorzolamide—glaucoma	5.36e-05	0.000313	CcSEcCtD
Bupropion—Body temperature increased—Dorzolamide—glaucoma	5.36e-05	0.000313	CcSEcCtD
Bupropion—Tension—Betaxolol—glaucoma	5.36e-05	0.000312	CcSEcCtD
Bupropion—SLC6A2—NRF2 pathway—GSTM1—glaucoma	5.36e-05	0.00273	CbGpPWpGaD
Bupropion—Sinusitis—Timolol—glaucoma	5.35e-05	0.000312	CcSEcCtD
Bupropion—Dysgeusia—Betaxolol—glaucoma	5.35e-05	0.000312	CcSEcCtD
Bupropion—Arthralgia—Clonidine—glaucoma	5.34e-05	0.000311	CcSEcCtD
Bupropion—Chest pain—Clonidine—glaucoma	5.34e-05	0.000311	CcSEcCtD
Bupropion—Abdominal pain—Travoprost—glaucoma	5.34e-05	0.000311	CcSEcCtD
Bupropion—Anxiety—Clonidine—glaucoma	5.32e-05	0.00031	CcSEcCtD
Bupropion—Asthenia—Acetazolamide—glaucoma	5.31e-05	0.000309	CcSEcCtD
Bupropion—Dizziness—Bimatoprost—glaucoma	5.3e-05	0.000309	CcSEcCtD
Bupropion—Nervousness—Betaxolol—glaucoma	5.3e-05	0.000309	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	5.3e-05	0.000309	CcSEcCtD
Bupropion—Urticaria—Brinzolamide—glaucoma	5.3e-05	0.000309	CcSEcCtD
Bupropion—Feeling abnormal—Pilocarpine—glaucoma	5.28e-05	0.000308	CcSEcCtD
Bupropion—Discomfort—Clonidine—glaucoma	5.28e-05	0.000307	CcSEcCtD
Bupropion—Vomiting—Apraclonidine—glaucoma	5.26e-05	0.000307	CcSEcCtD
Bupropion—Muscle spasms—Betaxolol—glaucoma	5.25e-05	0.000306	CcSEcCtD
Bupropion—Gastrointestinal pain—Pilocarpine—glaucoma	5.24e-05	0.000305	CcSEcCtD
Bupropion—Hypersensitivity—Brimonidine—glaucoma	5.23e-05	0.000305	CcSEcCtD
Bupropion—Dry mouth—Clonidine—glaucoma	5.22e-05	0.000304	CcSEcCtD
Bupropion—Dermatitis—Apraclonidine—glaucoma	5.21e-05	0.000304	CcSEcCtD
Bupropion—Headache—Apraclonidine—glaucoma	5.18e-05	0.000302	CcSEcCtD
Bupropion—Confusional state—Clonidine—glaucoma	5.16e-05	0.000301	CcSEcCtD
Bupropion—Vision blurred—Betaxolol—glaucoma	5.15e-05	0.0003	CcSEcCtD
Bupropion—Rhinitis—Timolol—glaucoma	5.14e-05	0.000299	CcSEcCtD
Bupropion—Oedema—Clonidine—glaucoma	5.12e-05	0.000298	CcSEcCtD
Bupropion—Tremor—Betaxolol—glaucoma	5.12e-05	0.000298	CcSEcCtD
Bupropion—SLC6A3—Neuronal System—SLC6A1—glaucoma	5.1e-05	0.0026	CbGpPWpGaD
Bupropion—Hallucination—Timolol—glaucoma	5.1e-05	0.000297	CcSEcCtD
Bupropion—Asthenia—Brimonidine—glaucoma	5.1e-05	0.000297	CcSEcCtD
Bupropion—Infection—Clonidine—glaucoma	5.08e-05	0.000296	CcSEcCtD
Bupropion—Body temperature increased—Pilocarpine—glaucoma	5.07e-05	0.000295	CcSEcCtD
Bupropion—Abdominal pain—Pilocarpine—glaucoma	5.07e-05	0.000295	CcSEcCtD
Bupropion—Ill-defined disorder—Betaxolol—glaucoma	5.07e-05	0.000295	CcSEcCtD
Bupropion—Diarrhoea—Acetazolamide—glaucoma	5.06e-05	0.000295	CcSEcCtD
Bupropion—Rash—Bimatoprost—glaucoma	5.06e-05	0.000295	CcSEcCtD
Bupropion—Dermatitis—Bimatoprost—glaucoma	5.05e-05	0.000295	CcSEcCtD
Bupropion—Oedema peripheral—Timolol—glaucoma	5.05e-05	0.000294	CcSEcCtD
Bupropion—Anaemia—Betaxolol—glaucoma	5.05e-05	0.000294	CcSEcCtD
Bupropion—Shock—Clonidine—glaucoma	5.04e-05	0.000294	CcSEcCtD
Bupropion—Connective tissue disorder—Timolol—glaucoma	5.03e-05	0.000293	CcSEcCtD
Bupropion—Pruritus—Brimonidine—glaucoma	5.02e-05	0.000293	CcSEcCtD
Bupropion—Headache—Bimatoprost—glaucoma	5.02e-05	0.000293	CcSEcCtD
Bupropion—Nervous system disorder—Clonidine—glaucoma	5.02e-05	0.000293	CcSEcCtD
Bupropion—Thrombocytopenia—Clonidine—glaucoma	5.01e-05	0.000292	CcSEcCtD
Bupropion—Hypersensitivity—Dorzolamide—glaucoma	5e-05	0.000291	CcSEcCtD
Bupropion—Tachycardia—Clonidine—glaucoma	5e-05	0.000291	CcSEcCtD
Bupropion—Hypersensitivity—Travoprost—glaucoma	4.98e-05	0.00029	CcSEcCtD
Bupropion—Skin disorder—Clonidine—glaucoma	4.97e-05	0.00029	CcSEcCtD
Bupropion—Hyperhidrosis—Clonidine—glaucoma	4.95e-05	0.000288	CcSEcCtD
Bupropion—Visual impairment—Timolol—glaucoma	4.94e-05	0.000288	CcSEcCtD
Bupropion—Malaise—Betaxolol—glaucoma	4.92e-05	0.000287	CcSEcCtD
Bupropion—Nausea—Apraclonidine—glaucoma	4.91e-05	0.000286	CcSEcCtD
Bupropion—Hypersensitivity—Brinzolamide—glaucoma	4.91e-05	0.000286	CcSEcCtD
Bupropion—Vertigo—Betaxolol—glaucoma	4.91e-05	0.000286	CcSEcCtD
Bupropion—Syncope—Betaxolol—glaucoma	4.9e-05	0.000285	CcSEcCtD
Bupropion—Dizziness—Acetazolamide—glaucoma	4.89e-05	0.000285	CcSEcCtD
Bupropion—Anorexia—Clonidine—glaucoma	4.88e-05	0.000284	CcSEcCtD
Bupropion—Asthenia—Dorzolamide—glaucoma	4.87e-05	0.000284	CcSEcCtD
Bupropion—Asthenia—Travoprost—glaucoma	4.85e-05	0.000282	CcSEcCtD
Bupropion—Palpitations—Betaxolol—glaucoma	4.82e-05	0.000281	CcSEcCtD
Bupropion—Pruritus—Dorzolamide—glaucoma	4.8e-05	0.00028	CcSEcCtD
Bupropion—Loss of consciousness—Betaxolol—glaucoma	4.8e-05	0.00028	CcSEcCtD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.8e-05	0.00245	CbGpPWpGaD
Bupropion—Eye disorder—Timolol—glaucoma	4.79e-05	0.000279	CcSEcCtD
Bupropion—Asthenia—Brinzolamide—glaucoma	4.78e-05	0.000279	CcSEcCtD
Bupropion—Hypotension—Clonidine—glaucoma	4.78e-05	0.000279	CcSEcCtD
Bupropion—Pruritus—Travoprost—glaucoma	4.78e-05	0.000279	CcSEcCtD
Bupropion—Tinnitus—Timolol—glaucoma	4.78e-05	0.000278	CcSEcCtD
Bupropion—Cough—Betaxolol—glaucoma	4.76e-05	0.000278	CcSEcCtD
Bupropion—Nausea—Bimatoprost—glaucoma	4.76e-05	0.000278	CcSEcCtD
Bupropion—Cardiac disorder—Timolol—glaucoma	4.76e-05	0.000277	CcSEcCtD
Bupropion—SLC6A3—NRF2 pathway—GSTM1—glaucoma	4.74e-05	0.00242	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.73e-05	0.00241	CbGpPWpGaD
Bupropion—Hypersensitivity—Pilocarpine—glaucoma	4.72e-05	0.000275	CcSEcCtD
Bupropion—Pruritus—Brinzolamide—glaucoma	4.72e-05	0.000275	CcSEcCtD
Bupropion—Vomiting—Acetazolamide—glaucoma	4.7e-05	0.000274	CcSEcCtD
Bupropion—Dizziness—Brimonidine—glaucoma	4.7e-05	0.000274	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Clonidine—glaucoma	4.66e-05	0.000272	CcSEcCtD
Bupropion—Angiopathy—Timolol—glaucoma	4.65e-05	0.000271	CcSEcCtD
Bupropion—Chest pain—Betaxolol—glaucoma	4.65e-05	0.000271	CcSEcCtD
Bupropion—Arthralgia—Betaxolol—glaucoma	4.65e-05	0.000271	CcSEcCtD
Bupropion—Myalgia—Betaxolol—glaucoma	4.65e-05	0.000271	CcSEcCtD
Bupropion—Diarrhoea—Dorzolamide—glaucoma	4.64e-05	0.000271	CcSEcCtD
Bupropion—Headache—Acetazolamide—glaucoma	4.64e-05	0.00027	CcSEcCtD
Bupropion—Anxiety—Betaxolol—glaucoma	4.63e-05	0.00027	CcSEcCtD
Bupropion—Insomnia—Clonidine—glaucoma	4.63e-05	0.00027	CcSEcCtD
Bupropion—Immune system disorder—Timolol—glaucoma	4.63e-05	0.00027	CcSEcCtD
Bupropion—Diarrhoea—Travoprost—glaucoma	4.62e-05	0.000269	CcSEcCtD
Bupropion—Mediastinal disorder—Timolol—glaucoma	4.62e-05	0.000269	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	4.62e-05	0.000269	CcSEcCtD
Bupropion—Asthenia—Pilocarpine—glaucoma	4.6e-05	0.000268	CcSEcCtD
Bupropion—Paraesthesia—Clonidine—glaucoma	4.6e-05	0.000268	CcSEcCtD
Bupropion—Discomfort—Betaxolol—glaucoma	4.59e-05	0.000268	CcSEcCtD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.59e-05	0.00234	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	4.58e-05	0.00234	CbGpPWpGaD
Bupropion—Arrhythmia—Timolol—glaucoma	4.58e-05	0.000267	CcSEcCtD
Bupropion—Dyspnoea—Clonidine—glaucoma	4.56e-05	0.000266	CcSEcCtD
Bupropion—Diarrhoea—Brinzolamide—glaucoma	4.56e-05	0.000266	CcSEcCtD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.55e-05	0.00232	CbGpPWpGaD
Bupropion—Somnolence—Clonidine—glaucoma	4.55e-05	0.000265	CcSEcCtD
Bupropion—Dry mouth—Betaxolol—glaucoma	4.55e-05	0.000265	CcSEcCtD
Bupropion—Pruritus—Pilocarpine—glaucoma	4.53e-05	0.000264	CcSEcCtD
Bupropion—Alopecia—Timolol—glaucoma	4.53e-05	0.000264	CcSEcCtD
Bupropion—Confusional state—Betaxolol—glaucoma	4.49e-05	0.000262	CcSEcCtD
Bupropion—Mental disorder—Timolol—glaucoma	4.49e-05	0.000262	CcSEcCtD
Bupropion—Dizziness—Dorzolamide—glaucoma	4.49e-05	0.000261	CcSEcCtD
Bupropion—Rash—Brimonidine—glaucoma	4.48e-05	0.000261	CcSEcCtD
Bupropion—Dermatitis—Brimonidine—glaucoma	4.47e-05	0.000261	CcSEcCtD
Bupropion—Dizziness—Travoprost—glaucoma	4.47e-05	0.00026	CcSEcCtD
Bupropion—Malnutrition—Timolol—glaucoma	4.46e-05	0.00026	CcSEcCtD
Bupropion—Oedema—Betaxolol—glaucoma	4.46e-05	0.00026	CcSEcCtD
Bupropion—Headache—Brimonidine—glaucoma	4.45e-05	0.000259	CcSEcCtD
Bupropion—Decreased appetite—Clonidine—glaucoma	4.45e-05	0.000259	CcSEcCtD
Bupropion—CYP1A2—Phase II conjugation—GSTT1—glaucoma	4.43e-05	0.00226	CbGpPWpGaD
Bupropion—Infection—Betaxolol—glaucoma	4.43e-05	0.000258	CcSEcCtD
Bupropion—Gastrointestinal disorder—Clonidine—glaucoma	4.42e-05	0.000258	CcSEcCtD
Bupropion—Fatigue—Clonidine—glaucoma	4.41e-05	0.000257	CcSEcCtD
Bupropion—Dizziness—Brinzolamide—glaucoma	4.41e-05	0.000257	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—GSTT1—glaucoma	4.4e-05	0.00225	CbGpPWpGaD
Bupropion—Nausea—Acetazolamide—glaucoma	4.4e-05	0.000256	CcSEcCtD
Bupropion—Diarrhoea—Pilocarpine—glaucoma	4.39e-05	0.000256	CcSEcCtD
Bupropion—Shock—Betaxolol—glaucoma	4.38e-05	0.000256	CcSEcCtD
Bupropion—Tension—Timolol—glaucoma	4.38e-05	0.000255	CcSEcCtD
Bupropion—Pain—Clonidine—glaucoma	4.38e-05	0.000255	CcSEcCtD
Bupropion—Constipation—Clonidine—glaucoma	4.38e-05	0.000255	CcSEcCtD
Bupropion—Nervous system disorder—Betaxolol—glaucoma	4.37e-05	0.000255	CcSEcCtD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	4.37e-05	0.00223	CbGpPWpGaD
Bupropion—Dysgeusia—Timolol—glaucoma	4.37e-05	0.000255	CcSEcCtD
Bupropion—Thrombocytopenia—Betaxolol—glaucoma	4.36e-05	0.000254	CcSEcCtD
Bupropion—Tachycardia—Betaxolol—glaucoma	4.35e-05	0.000253	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—CYP1B1—glaucoma	4.35e-05	0.00222	CbGpPWpGaD
Bupropion—Nervousness—Timolol—glaucoma	4.33e-05	0.000253	CcSEcCtD
Bupropion—Skin disorder—Betaxolol—glaucoma	4.33e-05	0.000252	CcSEcCtD
Bupropion—Vomiting—Dorzolamide—glaucoma	4.31e-05	0.000251	CcSEcCtD
Bupropion—CYP2E1—Biological oxidations—GSTT1—glaucoma	4.31e-05	0.0022	CbGpPWpGaD
Bupropion—Hyperhidrosis—Betaxolol—glaucoma	4.31e-05	0.000251	CcSEcCtD
Bupropion—Rash—Dorzolamide—glaucoma	4.28e-05	0.000249	CcSEcCtD
Bupropion—Dermatitis—Dorzolamide—glaucoma	4.27e-05	0.000249	CcSEcCtD
Bupropion—Rash—Travoprost—glaucoma	4.26e-05	0.000248	CcSEcCtD
Bupropion—Dermatitis—Travoprost—glaucoma	4.25e-05	0.000248	CcSEcCtD
Bupropion—Headache—Dorzolamide—glaucoma	4.25e-05	0.000248	CcSEcCtD
Bupropion—Anorexia—Betaxolol—glaucoma	4.25e-05	0.000248	CcSEcCtD
Bupropion—Vomiting—Brinzolamide—glaucoma	4.24e-05	0.000247	CcSEcCtD
Bupropion—Dizziness—Pilocarpine—glaucoma	4.24e-05	0.000247	CcSEcCtD
Bupropion—Headache—Travoprost—glaucoma	4.23e-05	0.000247	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.23e-05	0.00216	CbGpPWpGaD
Bupropion—Nausea—Brimonidine—glaucoma	4.22e-05	0.000246	CcSEcCtD
Bupropion—Feeling abnormal—Clonidine—glaucoma	4.22e-05	0.000246	CcSEcCtD
Bupropion—Rash—Brinzolamide—glaucoma	4.2e-05	0.000245	CcSEcCtD
Bupropion—Vision blurred—Timolol—glaucoma	4.2e-05	0.000245	CcSEcCtD
Bupropion—Dermatitis—Brinzolamide—glaucoma	4.2e-05	0.000245	CcSEcCtD
Bupropion—Gastrointestinal pain—Clonidine—glaucoma	4.19e-05	0.000244	CcSEcCtD
Bupropion—Headache—Brinzolamide—glaucoma	4.18e-05	0.000244	CcSEcCtD
Bupropion—Hypotension—Betaxolol—glaucoma	4.16e-05	0.000243	CcSEcCtD
Bupropion—Angioedema—Timolol—glaucoma	4.08e-05	0.000238	CcSEcCtD
Bupropion—Vomiting—Pilocarpine—glaucoma	4.07e-05	0.000238	CcSEcCtD
Bupropion—Urticaria—Clonidine—glaucoma	4.07e-05	0.000237	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Betaxolol—glaucoma	4.06e-05	0.000237	CcSEcCtD
Bupropion—Abdominal pain—Clonidine—glaucoma	4.05e-05	0.000236	CcSEcCtD
Bupropion—Body temperature increased—Clonidine—glaucoma	4.05e-05	0.000236	CcSEcCtD
Bupropion—Rash—Pilocarpine—glaucoma	4.04e-05	0.000236	CcSEcCtD
Bupropion—Dermatitis—Pilocarpine—glaucoma	4.04e-05	0.000235	CcSEcCtD
Bupropion—Insomnia—Betaxolol—glaucoma	4.03e-05	0.000235	CcSEcCtD
Bupropion—Nausea—Dorzolamide—glaucoma	4.03e-05	0.000235	CcSEcCtD
Bupropion—Headache—Pilocarpine—glaucoma	4.02e-05	0.000234	CcSEcCtD
Bupropion—Nausea—Travoprost—glaucoma	4.01e-05	0.000234	CcSEcCtD
Bupropion—Vertigo—Timolol—glaucoma	4.01e-05	0.000234	CcSEcCtD
Bupropion—Paraesthesia—Betaxolol—glaucoma	4e-05	0.000233	CcSEcCtD
Bupropion—Syncope—Timolol—glaucoma	4e-05	0.000233	CcSEcCtD
Bupropion—Dyspnoea—Betaxolol—glaucoma	3.97e-05	0.000232	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—GSTM1—glaucoma	3.96e-05	0.00202	CbGpPWpGaD
Bupropion—Nausea—Brinzolamide—glaucoma	3.96e-05	0.000231	CcSEcCtD
Bupropion—Palpitations—Timolol—glaucoma	3.94e-05	0.00023	CcSEcCtD
Bupropion—Dyspepsia—Betaxolol—glaucoma	3.92e-05	0.000229	CcSEcCtD
Bupropion—Loss of consciousness—Timolol—glaucoma	3.92e-05	0.000229	CcSEcCtD
Bupropion—Cough—Timolol—glaucoma	3.89e-05	0.000227	CcSEcCtD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.89e-05	0.00198	CbGpPWpGaD
Bupropion—Decreased appetite—Betaxolol—glaucoma	3.87e-05	0.000226	CcSEcCtD
Bupropion—Hypertension—Timolol—glaucoma	3.85e-05	0.000224	CcSEcCtD
Bupropion—Gastrointestinal disorder—Betaxolol—glaucoma	3.85e-05	0.000224	CcSEcCtD
Bupropion—Fatigue—Betaxolol—glaucoma	3.84e-05	0.000224	CcSEcCtD
Bupropion—CYP2A6—Metabolism—NARFL—glaucoma	3.82e-05	0.00195	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CA5A—glaucoma	3.82e-05	0.00195	CbGpPWpGaD
Bupropion—Constipation—Betaxolol—glaucoma	3.81e-05	0.000222	CcSEcCtD
Bupropion—Pain—Betaxolol—glaucoma	3.81e-05	0.000222	CcSEcCtD
Bupropion—Nausea—Pilocarpine—glaucoma	3.81e-05	0.000222	CcSEcCtD
Bupropion—Myalgia—Timolol—glaucoma	3.8e-05	0.000221	CcSEcCtD
Bupropion—Arthralgia—Timolol—glaucoma	3.8e-05	0.000221	CcSEcCtD
Bupropion—Chest pain—Timolol—glaucoma	3.8e-05	0.000221	CcSEcCtD
Bupropion—Anxiety—Timolol—glaucoma	3.78e-05	0.000221	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	3.77e-05	0.00022	CcSEcCtD
Bupropion—Hypersensitivity—Clonidine—glaucoma	3.77e-05	0.00022	CcSEcCtD
Bupropion—Discomfort—Timolol—glaucoma	3.75e-05	0.000219	CcSEcCtD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.75e-05	0.00191	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—GSTT1—glaucoma	3.73e-05	0.0019	CbGpPWpGaD
Bupropion—Dry mouth—Timolol—glaucoma	3.71e-05	0.000216	CcSEcCtD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.7e-05	0.00189	CbGpPWpGaD
Bupropion—Asthenia—Clonidine—glaucoma	3.67e-05	0.000214	CcSEcCtD
Bupropion—Feeling abnormal—Betaxolol—glaucoma	3.67e-05	0.000214	CcSEcCtD
Bupropion—Confusional state—Timolol—glaucoma	3.67e-05	0.000214	CcSEcCtD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.65e-05	0.00186	CbGpPWpGaD
Bupropion—Oedema—Timolol—glaucoma	3.64e-05	0.000212	CcSEcCtD
Bupropion—Anaphylactic shock—Timolol—glaucoma	3.64e-05	0.000212	CcSEcCtD
Bupropion—Pruritus—Clonidine—glaucoma	3.62e-05	0.000211	CcSEcCtD
Bupropion—Infection—Timolol—glaucoma	3.62e-05	0.000211	CcSEcCtD
Bupropion—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	3.6e-05	0.00183	CbGpPWpGaD
Bupropion—Shock—Timolol—glaucoma	3.58e-05	0.000209	CcSEcCtD
Bupropion—Nervous system disorder—Timolol—glaucoma	3.57e-05	0.000208	CcSEcCtD
Bupropion—Urticaria—Betaxolol—glaucoma	3.54e-05	0.000206	CcSEcCtD
Bupropion—Skin disorder—Timolol—glaucoma	3.54e-05	0.000206	CcSEcCtD
Bupropion—Body temperature increased—Betaxolol—glaucoma	3.52e-05	0.000205	CcSEcCtD
Bupropion—Hyperhidrosis—Timolol—glaucoma	3.52e-05	0.000205	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—CYP1B1—glaucoma	3.51e-05	0.00179	CbGpPWpGaD
Bupropion—Diarrhoea—Clonidine—glaucoma	3.5e-05	0.000204	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—GSTM1—glaucoma	3.48e-05	0.00177	CbGpPWpGaD
Bupropion—Anorexia—Timolol—glaucoma	3.47e-05	0.000202	CcSEcCtD
Bupropion—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	3.46e-05	0.00176	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP1B1—glaucoma	3.44e-05	0.00175	CbGpPWpGaD
Bupropion—Hypotension—Timolol—glaucoma	3.4e-05	0.000198	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	3.39e-05	0.00173	CbGpPWpGaD
Bupropion—Dizziness—Clonidine—glaucoma	3.38e-05	0.000197	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Timolol—glaucoma	3.32e-05	0.000193	CcSEcCtD
Bupropion—Insomnia—Timolol—glaucoma	3.29e-05	0.000192	CcSEcCtD
Bupropion—Hypersensitivity—Betaxolol—glaucoma	3.28e-05	0.000191	CcSEcCtD
Bupropion—Paraesthesia—Timolol—glaucoma	3.27e-05	0.000191	CcSEcCtD
Bupropion—Vomiting—Clonidine—glaucoma	3.25e-05	0.00019	CcSEcCtD
Bupropion—Dyspnoea—Timolol—glaucoma	3.25e-05	0.000189	CcSEcCtD
Bupropion—Somnolence—Timolol—glaucoma	3.24e-05	0.000189	CcSEcCtD
Bupropion—Rash—Clonidine—glaucoma	3.23e-05	0.000188	CcSEcCtD
Bupropion—Dermatitis—Clonidine—glaucoma	3.22e-05	0.000188	CcSEcCtD
Bupropion—Headache—Clonidine—glaucoma	3.21e-05	0.000187	CcSEcCtD
Bupropion—Dyspepsia—Timolol—glaucoma	3.2e-05	0.000187	CcSEcCtD
Bupropion—Asthenia—Betaxolol—glaucoma	3.2e-05	0.000186	CcSEcCtD
Bupropion—Decreased appetite—Timolol—glaucoma	3.16e-05	0.000184	CcSEcCtD
Bupropion—Pruritus—Betaxolol—glaucoma	3.15e-05	0.000184	CcSEcCtD
Bupropion—Gastrointestinal disorder—Timolol—glaucoma	3.14e-05	0.000183	CcSEcCtD
Bupropion—Fatigue—Timolol—glaucoma	3.14e-05	0.000183	CcSEcCtD
Bupropion—Pain—Timolol—glaucoma	3.11e-05	0.000181	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.1e-05	0.00158	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NARFL—glaucoma	3.09e-05	0.00157	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CA5A—glaucoma	3.09e-05	0.00157	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.06e-05	0.00156	CbGpPWpGaD
Bupropion—Diarrhoea—Betaxolol—glaucoma	3.05e-05	0.000178	CcSEcCtD
Bupropion—Nausea—Clonidine—glaucoma	3.04e-05	0.000177	CcSEcCtD
Bupropion—CYP2C9—Biological oxidations—GSTT1—glaucoma	3.03e-05	0.00155	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NARFL—glaucoma	3.02e-05	0.00154	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CA5A—glaucoma	3.02e-05	0.00154	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3e-05	0.00153	CbGpPWpGaD
Bupropion—Feeling abnormal—Timolol—glaucoma	3e-05	0.000175	CcSEcCtD
Bupropion—Gastrointestinal pain—Timolol—glaucoma	2.98e-05	0.000174	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—CYP1B1—glaucoma	2.97e-05	0.00151	CbGpPWpGaD
Bupropion—Dizziness—Betaxolol—glaucoma	2.95e-05	0.000172	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	2.93e-05	0.00149	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	2.93e-05	0.00149	CbGpPWpGaD
Bupropion—Urticaria—Timolol—glaucoma	2.89e-05	0.000169	CcSEcCtD
Bupropion—Body temperature increased—Timolol—glaucoma	2.88e-05	0.000168	CcSEcCtD
Bupropion—Abdominal pain—Timolol—glaucoma	2.88e-05	0.000168	CcSEcCtD
Bupropion—Vomiting—Betaxolol—glaucoma	2.83e-05	0.000165	CcSEcCtD
Bupropion—CYP1A2—Phase II conjugation—GSTM1—glaucoma	2.82e-05	0.00144	CbGpPWpGaD
Bupropion—Rash—Betaxolol—glaucoma	2.81e-05	0.000164	CcSEcCtD
Bupropion—Dermatitis—Betaxolol—glaucoma	2.81e-05	0.000164	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—GSTM1—glaucoma	2.8e-05	0.00143	CbGpPWpGaD
Bupropion—Headache—Betaxolol—glaucoma	2.79e-05	0.000163	CcSEcCtD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.77e-05	0.00142	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	2.77e-05	0.00141	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—GSTM1—glaucoma	2.75e-05	0.0014	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.74e-05	0.0014	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	2.71e-05	0.00138	CbGpPWpGaD
Bupropion—Hypersensitivity—Timolol—glaucoma	2.68e-05	0.000156	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	2.67e-05	0.00136	CbGpPWpGaD
Bupropion—Nausea—Betaxolol—glaucoma	2.65e-05	0.000154	CcSEcCtD
Bupropion—CYP2C8—Metabolism—CA5A—glaucoma	2.61e-05	0.00133	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NARFL—glaucoma	2.61e-05	0.00133	CbGpPWpGaD
Bupropion—Asthenia—Timolol—glaucoma	2.61e-05	0.000152	CcSEcCtD
Bupropion—CYP1A2—Biological oxidations—GSTT1—glaucoma	2.59e-05	0.00132	CbGpPWpGaD
Bupropion—Pruritus—Timolol—glaucoma	2.58e-05	0.00015	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	2.53e-05	0.00129	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	2.53e-05	0.00129	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	2.5e-05	0.00128	CbGpPWpGaD
Bupropion—Diarrhoea—Timolol—glaucoma	2.49e-05	0.000145	CcSEcCtD
Bupropion—CYP2D6—Biological oxidations—CYP1B1—glaucoma	2.44e-05	0.00124	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP1B1—glaucoma	2.42e-05	0.00123	CbGpPWpGaD
Bupropion—Dizziness—Timolol—glaucoma	2.41e-05	0.00014	CcSEcCtD
Bupropion—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.4e-05	0.00123	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	2.38e-05	0.00122	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—GSTM1—glaucoma	2.37e-05	0.00121	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	2.34e-05	0.00119	CbGpPWpGaD
Bupropion—Vomiting—Timolol—glaucoma	2.31e-05	0.000135	CcSEcCtD
Bupropion—Rash—Timolol—glaucoma	2.3e-05	0.000134	CcSEcCtD
Bupropion—Dermatitis—Timolol—glaucoma	2.29e-05	0.000134	CcSEcCtD
Bupropion—Headache—Timolol—glaucoma	2.28e-05	0.000133	CcSEcCtD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.26e-05	0.00115	CbGpPWpGaD
Bupropion—Nausea—Timolol—glaucoma	2.16e-05	0.000126	CcSEcCtD
Bupropion—CYP2D6—Metabolism—CA5A—glaucoma	2.14e-05	0.00109	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NARFL—glaucoma	2.14e-05	0.00109	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CA5A—glaucoma	2.13e-05	0.00108	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NARFL—glaucoma	2.13e-05	0.00108	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	2.11e-05	0.00107	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP1B1—glaucoma	2.07e-05	0.00105	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	2.04e-05	0.00104	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTT1—glaucoma	2e-05	0.00102	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.95e-05	0.000994	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.93e-05	0.000986	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.93e-05	0.000984	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.92e-05	0.00098	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.91e-05	0.000972	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CA1—glaucoma	1.87e-05	0.000953	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CA5A—glaucoma	1.82e-05	0.000927	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NARFL—glaucoma	1.82e-05	0.000927	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CTSA—glaucoma	1.81e-05	0.000923	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.81e-05	0.000921	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.81e-05	0.000921	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CA2—glaucoma	1.71e-05	0.000871	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.65e-05	0.000842	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.63e-05	0.000831	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.59e-05	0.000813	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.57e-05	0.000802	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CA1—glaucoma	1.51e-05	0.000769	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CA1—glaucoma	1.48e-05	0.000753	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CTSA—glaucoma	1.46e-05	0.000744	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CTSA—glaucoma	1.43e-05	0.000729	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CA5A—glaucoma	1.4e-05	0.000715	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NARFL—glaucoma	1.4e-05	0.000715	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CA2—glaucoma	1.38e-05	0.000703	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CA2—glaucoma	1.35e-05	0.000689	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CA1—glaucoma	1.28e-05	0.000651	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.27e-05	0.00065	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.26e-05	0.000641	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CTSA—glaucoma	1.24e-05	0.00063	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—TXN—glaucoma	1.2e-05	0.000614	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CA2—glaucoma	1.17e-05	0.000595	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.14e-05	0.000582	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.14e-05	0.000582	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CA1—glaucoma	1.05e-05	0.000534	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CA1—glaucoma	1.04e-05	0.00053	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CTSA—glaucoma	1.01e-05	0.000517	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CTSA—glaucoma	1.01e-05	0.000513	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TXN—glaucoma	9.71e-06	0.000495	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CA2—glaucoma	9.58e-06	0.000489	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TXN—glaucoma	9.51e-06	0.000485	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CA2—glaucoma	9.5e-06	0.000484	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTT1—glaucoma	9.33e-06	0.000476	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.28e-06	0.000473	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.28e-06	0.000473	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CA1—glaucoma	8.87e-06	0.000453	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CTSA—glaucoma	8.59e-06	0.000438	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TXN—glaucoma	8.22e-06	0.000419	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CA2—glaucoma	8.12e-06	0.000414	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.93e-06	0.000405	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.93e-06	0.000405	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTT1—glaucoma	7.53e-06	0.000384	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.5e-06	0.000383	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ABCA1—glaucoma	7.44e-06	0.000379	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP1B1—glaucoma	7.44e-06	0.000379	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.43e-06	0.000379	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTT1—glaucoma	7.37e-06	0.000376	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CA1—glaucoma	6.85e-06	0.000349	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TXN—glaucoma	6.75e-06	0.000344	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TXN—glaucoma	6.69e-06	0.000341	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CTSA—glaucoma	6.63e-06	0.000338	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTT1—glaucoma	6.37e-06	0.000325	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CA2—glaucoma	6.26e-06	0.000319	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.11e-06	0.000311	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.05e-06	0.000309	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP1B1—glaucoma	6e-06	0.000306	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ABCA1—glaucoma	6e-06	0.000306	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTM1—glaucoma	5.94e-06	0.000303	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP1B1—glaucoma	5.88e-06	0.0003	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ABCA1—glaucoma	5.88e-06	0.0003	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TXN—glaucoma	5.72e-06	0.000292	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—MTHFR—glaucoma	5.25e-06	0.000268	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTT1—glaucoma	5.23e-06	0.000267	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.22e-06	0.000266	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTT1—glaucoma	5.19e-06	0.000265	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.17e-06	0.000264	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.14e-06	0.000262	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP1B1—glaucoma	5.08e-06	0.000259	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ABCA1—glaucoma	5.08e-06	0.000259	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—APOE—glaucoma	4.89e-06	0.000249	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CAV1—glaucoma	4.85e-06	0.000247	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTM1—glaucoma	4.8e-06	0.000245	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTM1—glaucoma	4.7e-06	0.00024	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTT1—glaucoma	4.43e-06	0.000226	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TXN—glaucoma	4.41e-06	0.000225	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—MTHFR—glaucoma	4.24e-06	0.000216	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.18e-06	0.000213	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP1B1—glaucoma	4.17e-06	0.000213	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ABCA1—glaucoma	4.17e-06	0.000213	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—MTHFR—glaucoma	4.15e-06	0.000212	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ABCA1—glaucoma	4.13e-06	0.000211	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP1B1—glaucoma	4.13e-06	0.000211	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTM1—glaucoma	4.06e-06	0.000207	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—APOE—glaucoma	3.95e-06	0.000201	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CAV1—glaucoma	3.91e-06	0.000199	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—APOE—glaucoma	3.86e-06	0.000197	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CAV1—glaucoma	3.83e-06	0.000195	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NOS3—glaucoma	3.66e-06	0.000187	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—MTHFR—glaucoma	3.59e-06	0.000183	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.57e-06	0.000182	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ABCA1—glaucoma	3.53e-06	0.00018	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP1B1—glaucoma	3.53e-06	0.00018	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTT1—glaucoma	3.42e-06	0.000175	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS2—glaucoma	3.35e-06	0.000171	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—APOE—glaucoma	3.34e-06	0.00017	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTM1—glaucoma	3.33e-06	0.00017	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CAV1—glaucoma	3.31e-06	0.000169	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTM1—glaucoma	3.3e-06	0.000169	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NOS3—glaucoma	2.96e-06	0.000151	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—MTHFR—glaucoma	2.95e-06	0.00015	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—MTHFR—glaucoma	2.92e-06	0.000149	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NOS3—glaucoma	2.9e-06	0.000148	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTM1—glaucoma	2.82e-06	0.000144	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—APOE—glaucoma	2.74e-06	0.00014	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ABCA1—glaucoma	2.73e-06	0.000139	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP1B1—glaucoma	2.73e-06	0.000139	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—APOE—glaucoma	2.72e-06	0.000139	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CAV1—glaucoma	2.72e-06	0.000139	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS2—glaucoma	2.7e-06	0.000138	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CAV1—glaucoma	2.69e-06	0.000137	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS2—glaucoma	2.65e-06	0.000135	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NOS3—glaucoma	2.5e-06	0.000128	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—MTHFR—glaucoma	2.5e-06	0.000127	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—APOE—glaucoma	2.32e-06	0.000119	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CAV1—glaucoma	2.3e-06	0.000117	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS2—glaucoma	2.29e-06	0.000117	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTM1—glaucoma	2.18e-06	0.000111	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NOS3—glaucoma	2.05e-06	0.000105	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NOS3—glaucoma	2.04e-06	0.000104	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—MTHFR—glaucoma	1.93e-06	9.82e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS2—glaucoma	1.88e-06	9.58e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS2—glaucoma	1.86e-06	9.5e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—APOE—glaucoma	1.79e-06	9.15e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CAV1—glaucoma	1.78e-06	9.06e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NOS3—glaucoma	1.74e-06	8.88e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS2—glaucoma	1.59e-06	8.12e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NOS3—glaucoma	1.34e-06	6.85e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS2—glaucoma	1.23e-06	6.27e-05	CbGpPWpGaD
